Customer case
Empowering Decentralized Clinical Trials with Compliant Digital Tools
The customer partnered with NNIT to create a scalable, compliant digital ecosystem for decentralized clinical trials with digital biomarkers and remote patient monitoring.
Enabling decentralized clinical trials with digital biomarkers
The customer partnered with NNIT to create a scalable, compliant digital ecosystem for clinical trials, enabling reliable patient-focused studies with digital biomarkers, remote patient monitoring to achieve measurable business and patient benefits.
The solution supports faster trial execution, reduced operational complexity, and higher-quality, real-time data. Patients benefit from fewer site visits, more convenient participation, and closer health monitoring, while the customer gains accelerated decision-making, improved participant recruitment and retention, and supporting evidence for regulatory interactions.
Case in brief
Challenge: Deploy digital biomarkers and remote patient monitoring in a GCP/GxP-regulated environment.
Solution: A unified platform for decentralized clinical trials.
Benefit: Faster execution, less complexity, and stronger clinical trial data integrity.
Meeting clinical standards in a digital world
The customer set out to enhance their clinical research by implementing digital biomarkers and remote patient monitoring solutions. Operating in a GCP/GxP-regulated environment, they needed to meet strict compliance standards while also ensuring user-friendly technology and ongoing patient engagement.
Without a unified digital infrastructure, clinical trial progress risked becoming fragmented, labor-intensive, and slower to produce actionable insights, ultimately delaying potential benefits for patients.
Building a unified, compliant digital ecosystem
To reach their goal, the customer collaborated with NNIT to create a compliant digital ecosystem that enables seamless integration of digital biomarkers into clinical trials. The joint approach consisted of mobile app development, cloud-based data processing, clinical science and operations and device metadata management, while enabling collaboration across research teams and external partners.
The solution delivered standardized and scalable digital trial capabilities, real-time access to validated sensor data, reduced manual processes, improved study oversight, audit readiness, and support for clinical trial data integrity.
"Digital clinical trials should reduce the burden on patients while giving researchers access to reliable, timely data. That balance was central to this collaboration.”
Monika Zbytniewska-Megret, Advanced Business Consultant, NNIT
NNIT’s Mark: Collaboration in action
Through close collaboration, the customer benefited from NNIT’s experience in compliant digital transformation for clinical trials. NNIT provided strategic guidance, technical expertise, and hands-on support throughout design, validation, and deployment.
The outcome was a robust, scalable digital foundation that enables the customer to launch new digitally enabled studies faster, reuse validated components across programs, reduce compliance risk, and strengthen patient-centric trial design.
Related Insights
Life Sciences, Clinical, Compliance, Digital Manufacturing, Quality, Regulatory Affairs, Smart supply-chain
Webinar: Inside the NDC-12 Industry Pilot
Life Sciences, Clinical, Regulatory Affairs
Webinar: Content Governance in the Age of AI: Preparing Pharmaceutical Organisations for ePI and FHIR I by Docuvera & NNIT
Life Sciences, Data, Digital Manufacturing
Webinar: Advancing Digital Manufacturing with Ignition 8.3
Life Sciences, Data, Digital Manufacturing
Webinar: Unified Namespace: Building a Scalable Data Hub for Manufacturing
Life Sciences, Digital Manufacturing, Quality, Regulatory Affairs
The Data Revolution in Pharma: How FHIR enables next level business outcomes for Quality, Manufacturing, and Regulatory
Life Sciences, Data, Regulatory Affairs, Smart supply-chain
The NDC-12 Cross-Industry Pilot: Key Findings & Insights From Phase 0
Life Sciences, AI, Data
From Hype to Reality: Architectural, Strategic, and Data Lessons for AI in Pharma
Life Sciences, Clinical, Data, Digital Manufacturing, Drug Safety, Regulatory Affairs, Smart supply-chain
How to build a universal translator for pharma data with FHIR
Life Sciences, AI, Clinical, Data, Drug Safety, Regulatory Affairs
Three priorities that will shape Life Sciences R&D through 2026